Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing methoxy polyethylene glycol-epoetin beta (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methoxy polyethylene glycol-epoetin beta (substance) |
Inferred relationship |
Some |
|
Methoxy polyethylene glycol-epoetin beta 200micrograms/mL injection solution 1mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methoxy polyethylene glycol-epoetin beta (substance) |
Inferred relationship |
Some |
|
Methoxy polyethylene glycol-epoetin beta 100micrograms/mL injection solution 1mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methoxy polyethylene glycol-epoetin beta (substance) |
Inferred relationship |
Some |
|
Methoxy polyethylene glycol-epoetin beta 50micrograms/mL injection solution 1mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methoxy polyethylene glycol-epoetin beta (substance) |
Inferred relationship |
Some |
|
Methoxy polyethylene glycol-epoetin beta 75micrograms injection solution 0.3mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methoxy polyethylene glycol-epoetin beta (substance) |
Inferred relationship |
Some |
|
Methoxy polyethylene glycol-epoetin beta 250micrograms injection solution 0.3mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methoxy polyethylene glycol-epoetin beta (substance) |
Inferred relationship |
Some |
|
Methoxy polyethylene glycol-epoetin beta 800micrograms injection solution 0.6mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methoxy polyethylene glycol-epoetin beta (substance) |
Inferred relationship |
Some |
|
Methoxy polyethylene glycol-epoetin beta 400micrograms injection solution 0.6mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methoxy polyethylene glycol-epoetin beta (substance) |
Inferred relationship |
Some |
|
Methoxy polyethylene glycol-epoetin beta 600micrograms injection solution 0.6mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methoxy polyethylene glycol-epoetin beta (substance) |
Inferred relationship |
Some |
|
Methoxy polyethylene glycol-epoetin beta 300micrograms/mL injection solution 1mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methoxy polyethylene glycol-epoetin beta (substance) |
Inferred relationship |
Some |
|
Methoxy polyethylene glycol-epoetin beta 200micrograms injection solution 0.3mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methoxy polyethylene glycol-epoetin beta (substance) |
Inferred relationship |
Some |
|
Methoxy polyethylene glycol-epoetin beta 50micrograms injection solution 0.3mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methoxy polyethylene glycol-epoetin beta (substance) |
Inferred relationship |
Some |
|
Methoxy polyethylene glycol-epoetin beta 150micrograms injection solution 0.3mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methoxy polyethylene glycol-epoetin beta (substance) |
Inferred relationship |
Some |
|
Methoxy polyethylene glycol-epoetin beta 1000micrograms/mL injection solution 1mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methoxy polyethylene glycol-epoetin beta (substance) |
Inferred relationship |
Some |
|
Methoxy polyethylene glycol-epoetin beta 400micrograms/mL injection solution 1mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methoxy polyethylene glycol-epoetin beta (substance) |
Inferred relationship |
Some |
|
Methoxy polyethylene glycol-epoetin beta 600micrograms/mL injection solution 1mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methoxy polyethylene glycol-epoetin beta (substance) |
Inferred relationship |
Some |
|
Product containing precisely methoxy polyethylene glycol-epoetin beta 150 microgram/0.3 milliliter conventional release solution for injection syringe |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Methoxy polyethylene glycol-epoetin beta (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely methoxy polyethylene glycol-epoetin beta 150 microgram/0.3 milliliter conventional release solution for injection syringe |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Methoxy polyethylene glycol-epoetin beta (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely methoxy polyethylene glycol-epoetin beta 200 microgram/0.3 milliliter conventional release solution for injection syringe |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Methoxy polyethylene glycol-epoetin beta (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely methoxy polyethylene glycol-epoetin beta 200 microgram/0.3 milliliter conventional release solution for injection syringe |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Methoxy polyethylene glycol-epoetin beta (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely methoxy polyethylene glycol-epoetin beta 250 microgram/0.3 milliliter conventional release solution for injection syringe |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Methoxy polyethylene glycol-epoetin beta (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely methoxy polyethylene glycol-epoetin beta 250 microgram/0.3 milliliter conventional release solution for injection syringe |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Methoxy polyethylene glycol-epoetin beta (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely methoxy polyethylene glycol-epoetin beta 50 microgram/0.3 milliliter conventional release solution for injection syringe |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Methoxy polyethylene glycol-epoetin beta (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely methoxy polyethylene glycol-epoetin beta 50 microgram/0.3 milliliter conventional release solution for injection syringe |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Methoxy polyethylene glycol-epoetin beta (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely methoxy polyethylene glycol-epoetin beta 75 microgram/0.3 milliliter conventional release solution for injection syringe |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Methoxy polyethylene glycol-epoetin beta (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely methoxy polyethylene glycol-epoetin beta 75 microgram/0.3 milliliter conventional release solution for injection syringe |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Methoxy polyethylene glycol-epoetin beta (substance) |
Inferred relationship |
Some |
1 |
Methoxy polyethylene glycol-epoetin beta 250 microgram/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Methoxy polyethylene glycol-epoetin beta (substance) |
Inferred relationship |
Some |
1 |
Methoxy polyethylene glycol-epoetin beta 250 microgram/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Methoxy polyethylene glycol-epoetin beta (substance) |
Inferred relationship |
Some |
1 |
Methoxy polyethylene glycol-epoetin beta 666.667 microgram/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Methoxy polyethylene glycol-epoetin beta (substance) |
Inferred relationship |
Some |
1 |
Methoxy polyethylene glycol-epoetin beta 666.667 microgram/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Methoxy polyethylene glycol-epoetin beta (substance) |
Inferred relationship |
Some |
1 |
Methoxy polyethylene glycol-epoetin beta 500 microgram/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Methoxy polyethylene glycol-epoetin beta (substance) |
Inferred relationship |
Some |
1 |
Methoxy polyethylene glycol-epoetin beta 500 microgram/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Methoxy polyethylene glycol-epoetin beta (substance) |
Inferred relationship |
Some |
1 |
Methoxy polyethylene glycol-epoetin beta 166.667 microgram/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Methoxy polyethylene glycol-epoetin beta (substance) |
Inferred relationship |
Some |
1 |
Methoxy polyethylene glycol-epoetin beta 166.667 microgram/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Methoxy polyethylene glycol-epoetin beta (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely methoxy polyethylene glycol-epoetin beta 833.333 microgram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Methoxy polyethylene glycol-epoetin beta (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely methoxy polyethylene glycol-epoetin beta 833.333 microgram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Methoxy polyethylene glycol-epoetin beta (substance) |
Inferred relationship |
Some |
1 |
Product containing methoxy polyethylene glycol-epoetin beta (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methoxy polyethylene glycol-epoetin beta (substance) |
Inferred relationship |
Some |
1 |
Methoxy polyethylene glycol-epoetin beta only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methoxy polyethylene glycol-epoetin beta (substance) |
Inferred relationship |
Some |
1 |
Product containing only methoxy polyethylene glycol-epoetin beta in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methoxy polyethylene glycol-epoetin beta (substance) |
Inferred relationship |
Some |
1 |
Product containing methoxy polyethylene glycol-epoetin beta in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methoxy polyethylene glycol-epoetin beta (substance) |
Inferred relationship |
Some |
1 |